Results 1 to 10 of about 462,597 (221)

Mechanisms of macular edema

open access: yesFrontiers in Medicine, 2023
Macular edema is the pathological accumulation of fluid in the central retina. It is a complication of many retinal diseases, including diabetic retinopathy, retinal vascular occlusions and uveitis, among others.
Cameron D. Haydinger   +3 more
semanticscholar   +4 more sources

Cytokines and the Pathogenesis of Macular Edema in Branch Retinal Vein Occlusion

open access: yesJournal of Ophthalmology, 2019
Branch retinal vein occlusion (BRVO) is a very common retinal vascular problem in patients with lifestyle-related diseases, such as hypertension and arteriosclerosis.
Hidetaka Noma   +2 more
doaj   +2 more sources

Edema macular cistoideo Macular cystoid edema

open access: yesMedisan, 2010
Se presentan 2 casos clínicos de pacientes con edema macular cistoideo, provocado por cirugía intraocular (por extracción extracapsular del cristalino y lente intraocular) y operación convencional del desprendimiento de retina, entre otras causas ...
Blanca Nieve Rey Estévez   +2 more
doaj   +1 more source

Cystoid macular edema

open access: yesClinical Ophthalmology, 2008
Tryfon G Rotsos1, Marilita M Moschos21Medical Retina Service, Moorfields Eye Hospital, London, UK; 2Department of Ophthalmology, University of Athens, GreeceAbstract: We review the epidemiology, pathophysiology, and etiology of cystoid macular edema (CME)
Tryfon G Rotsos, Marilita M Moschos
doaj   +4 more sources

Current Treatments for Diabetic Macular Edema

open access: yesInternational Journal of Molecular Sciences, 2023
Diabetic retinopathy is a major retinal disorder and a leading cause of blindness. Diabetic macular edema (DME) is an ocular complication in patients with diabetes, and it can impair vision significantly.
T. Tatsumi
semanticscholar   +1 more source

Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration

open access: yesPharmaceutics, 2023
Nowadays; intravitreal anti-vascular endothelial growth factor (VEGF) drugs are considered the first-line therapeutic strategy for treating macular exudative diseases; including wet age-related macular degeneration (w-AMD) and diabetic macular edema (DME)
L. Ferro Desideri   +3 more
semanticscholar   +1 more source

Interleukin-6 and Macular Edema: A Review of Outcomes with Inhibition

open access: yesInternational Journal of Molecular Sciences, 2023
This paper describes the current literature on the molecular pathophysiology of interleukin-6 (IL-6) in the genesis of macular edema and on the outcomes with IL-6 inhibitors in the treatment of non-infectious macular edema.
Janine Yang, David Goldberg, L. Sobrin
semanticscholar   +1 more source

Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications

open access: yesCells, 2022
Diabetic retinopathy (DR), with increasing incidence, is the major cause of vision loss and blindness worldwide in working-age adults. Diabetic macular edema (DME) remains the main cause of vision impairment in diabetic patients, with its pathogenesis ...
Jingfa Zhang   +6 more
semanticscholar   +1 more source

Involvement of Cytokines in the Pathogenesis of Diabetic Macular Edema

open access: yesInternational Journal of Molecular Sciences, 2021
Diabetic macular edema (DME) is a critical complication of diabetic retinopathy, a condition that arises from the breakdown of the blood–retinal barrier and the consequent increase in vascular permeability.
H. Noma, K. Yasuda, M. Shimura
semanticscholar   +1 more source

Regression of taxane-related cystoid macular edema after topical dorzolamide treatment: two case reports

open access: yesJournal of Medical Case Reports, 2021
Background Cystoid macular edema is a rare, vision-threatening side effect of the taxane family of anticancer agents. There is no established treatment or standard treatment protocol for taxane-related cystoid macular edema.
Mitsuru Otsubo   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy